Non-small cell lung cancer
Conditions
Interventions
Drug-loaded microsphere group:N/A
Blank microsphere group:N/A
Sponsors
Tianjin Cancer Hospital Airport Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Age range from 18 to 70 years old, gender unlimited; 2. According to the guidelines for the Diagnosis and Treatment of primary lung Cancer (2018 Edition), the patient was diagnosed as NSCLC by histopathology; 3. Complete case data; 4. The amount of hemoptysis exceeds 50ml per day; 5. ECOG PS score =2 points; 6. Expected survival > 6 months; 7. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with severe coagulation dysfunction that cannot be corrected; 2. Patients with arteriovenous fistula; 3. Leukocyte 176.8 µmol/L; AST and/or ALT > 2 times the normal upper limit); 5. Patients with active infection requiring antibiotic treatment; 6. Uncontrolled hypertension, diabetes, and cardiovascular disease with obvious symptoms; 7. Allergy to contrast agent; 8. Women with pregnancy or lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Remission rate and recurrence rate of hemoptysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| 1, 3, 6 months objective response rate;1, 3, 6 months disease control rate;Progression Free Survival;Overall Survival;Tumor marker(CEA?SCC?CYFRA21-1);the quality of life scores;ECOG PS score;pain assessment; | — |
Countries
China
Contacts
Public ContactTongguo Si
Tianjin Cancer Hospital Airport Hospital
Outcome results
None listed